rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2004-4-12
|
pubmed:abstractText |
Because microbicides will be applied topically in the vagina, the active agent must be formulated as a gel or cream by combining the active agent with suitable excipients. Although a number of in vitro methods have been developed for testing anti-HIV activity of microbicides, most of these methods have not been used for testing microbicides as a gel or cream.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0148-5717
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
143-8
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15076925-Anti-Infective Agents, Local,
pubmed-meshheading:15076925-Excipients,
pubmed-meshheading:15076925-HIV,
pubmed-meshheading:15076925-HIV Infections,
pubmed-meshheading:15076925-Humans,
pubmed-meshheading:15076925-Hydrogen-Ion Concentration,
pubmed-meshheading:15076925-Leukocytes, Mononuclear,
pubmed-meshheading:15076925-Lubrication,
pubmed-meshheading:15076925-Nonprescription Drugs,
pubmed-meshheading:15076925-Vaginal Creams, Foams, and Jellies,
pubmed-meshheading:15076925-Viscosity
|
pubmed:year |
2004
|
pubmed:articleTitle |
Measurement of anti-HIV activity of marketed vaginal products and excipients using a PBMC-based in vitro assay.
|
pubmed:affiliation |
Department of Pharmaceutical Sciences, School of Pharmacy, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, U.S. Gov't, P.H.S.,
Evaluation Studies
|